Company
Ahead Together
We unite science, technology and talent to get ahead of disease together.
Purpose, strategy and culture
Innovation to prevent and treat disease is at the heart of everything we do. We aim to positively impact the health of 2.5 billion people by the end of the decade.
At a glance
GSK has a significant footprint in the US across commercial, R&D, manufacturing, and corporate functions. We employ ~15,000 people across the US and have two corporate hubs.
View our policy positions
We have policies in place across GSK to ensure we meet the high standards we set ourselves as a company, and those that are expected of us externally.
Learn more about our views and our practices across a range of issues that are important to GSK, our patients and our stakeholders.
Latest press releases
- GSK sponsors 2025 National Senior Games as part of Sideline RSV campaign to raise awareness of RSV in older adults
- GSK announces extension of US Food and Drug Administration review period for Blenrep (belantamab mafodotin-blmf) in relapsed/refractory multiple myeloma
- GSK provides update on US FDA advisory committee review of Blenrep (belantamab mafodotin-blmf) combinations for patients with relapsed/refractory multiple myeloma
